Back
EHRA Premium Access

The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)

Session: ePoster session 2
Topic: Device Treatment
Speaker: Miss M. Van Der Heide (Amsterdam, NL)
Event: EHRA 2023

Congress Presentation

Add to my library

Like

About the speaker

Miss Myrthe Van Der Heide

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

9 more presentations in this session

Weight-loss management after catheter ablation of atrial fibrillation

Speaker: Miss A. Burbelka (Rzeszow, PL)

Access
Abstract
Slides
Like
Thumbnail

Cardiac hereditary diseases: genetic insights from a single center 15-year experience

Speaker: Doctor A. Porretta (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

The safety and efficacy of rotor ablation in right atrium after pulmonary vein isolation in patients with persistent atrial fibrillation

Speaker: Doctor A. Yoshida (Ono, JP)

Access
Abstract
Slides
Like
Thumbnail

Pitfalls and limitations in the assessment of the HV interval in a transcatheter aortic valve replacement population. A prospective analysis.

Speaker: Doctor C. Teres (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Lesion formation in irrigated RF-ablation is not linear, but monoexponential

Speaker: Doctor F. Bahlke (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePoster session 2

Speakers: Miss M. Van Der Heide, Miss A. Burbelka, Doctor A. Porretta, Doctor A. Yoshida, Doctor C. Teres...
Access
Like
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources